Invivyd, Inc. (IVVD) held its first quarter 2026 earnings conference call to review financial results and recent business developments.
Key Materials Now Available
Katie Falzone, Senior Vice President of Finance, announced that the company released a press release outlining Q1 2026 financial results and business highlights. Supporting slides from the webcast appear in the Investors section of the Invivyd website, under Press Releases and Events & Presentations.
Executive Leadership Participation
Marc Elia, Chairman of the Board of Directors, led the discussion. Joining him were Dr. Michael Mina, Chief Medical Officer; Dr. Robert Allen, Chief Scientific Officer; Tim Lee, Chief Commercial Officer; and Bill Duke, Chief Financial Officer, Principal Accounting Officer, and Principal Executive Officer.
Analyst Coverage
Analysts on the call included Joshua Schimmer from Cantor Fitzgerald & Co., Research Division; Patrick Trucchio from H.C. Wainwright & Co, LLC, Research Division; and Thomas Shrader from BTIG, LLC, Research Division.
Forward-Looking Statements Disclaimer
Speakers provided forward-looking statements on topics including corporate and commercial strategy, research and development efforts, regulatory plans, financial projections, and future outlook. These statements, covered under the Private Securities Litigation Reform Act, involve risks, assumptions, and uncertainties that could cause actual results to differ significantly from anticipated outcomes.
